Max Robotics — Global Service Robot Directory + US Certification

About

Johannes A. Langendijk is a leading authority in radiation oncology, with a primary focus on head and neck cancers. His research has been instrumental in advancing treatment paradigms for complex clinical scenarios, such as managing metastatic squamous cell carcinoma to the cervical lymph nodes from an unknown primary cancer. In his highly cited 2020 work, Langendijk comprehensively addressed the challenges of neck cancer with unknown primary (NCUP) in the HPV era, providing crucial guidance on diagnostic workup and therapeutic strategies that have shaped modern clinical practice. Beyond this, he has pioneered the integration of advanced radiation techniques, including intensity-modulated proton therapy (IMPT), with a particular emphasis on robustness evaluation and dose accumulation to minimize toxicity and improve patient outcomes. His 2019 study on robustness evaluation in head and neck IMPT exemplifies his commitment to precision and safety in radiotherapy. With over 42 citations on his seminal NCUP paper alone, Langendijk’s work has had a profound impact on both clinical decision-making and technological innovation. His contributions continue to influence the next generation of radiation oncologists, offering a model of rigorous, patient-centered research that bridges the gap between emerging technology and real-world application.